134 related articles for article (PubMed ID: 33234933)
1. Gastrointestinal Stromal Tumor Incidentally Detected on 18F-Fluciclovine PET/CT.
Raghavan K; Flavell RR; Westphalen AC; Behr SC
Clin Nucl Med; 2021 Apr; 46(4):345-347. PubMed ID: 33234933
[TBL] [Abstract][Full Text] [Related]
2. Incidentally Detected Oropharyngeal Squamous Cell Carcinoma on 18F-Fluciclovine PET/CT.
Raghavan K; Wen KW; Small EJ; Ha P; Flavell RR
Clin Nucl Med; 2019 May; 44(5):e367-e369. PubMed ID: 30829856
[TBL] [Abstract][Full Text] [Related]
3. Recurrent Malignant Melanoma Detected on 18F-Fluciclovine PET/CT Imaging for Prostate Cancer.
Teoh EJ; Tsakok MT; Bradley KM; Hyde K; Subesinghe M; Gleeson FV
Clin Nucl Med; 2017 Oct; 42(10):803-804. PubMed ID: 28806256
[TBL] [Abstract][Full Text] [Related]
4. Prostate Cancer Liver Metastases Presenting as Relatively Photopenic Lesions on 18F-Fluciclovine PET/CT.
Baiomy A; Martiniova L; Efstathiou E; Schuster DM; Ravizzini G
Clin Nucl Med; 2021 Apr; 46(4):e240-e241. PubMed ID: 33208612
[TBL] [Abstract][Full Text] [Related]
5. Superscan 18F-Fluciclovine PET/CT of PSA-Negative Prostate Cancer Bone Metastases.
Chen B; Macapinlac HA; Lu Y
Clin Nucl Med; 2019 Apr; 44(4):337-338. PubMed ID: 30688749
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of 18F-fluciclovine PET/CT for regional lymph node metastases in patients with primary prostate cancer: a multicenter phase II clinical trial.
Suzuki H; Jinnouchi S; Kaji Y; Kishida T; Kinoshita H; Yamaguchi S; Tobe T; Okamura T; Kawakita M; Furukawa J; Otaka A; Kakehi Y
Jpn J Clin Oncol; 2019 Sep; 49(9):803-811. PubMed ID: 31095314
[TBL] [Abstract][Full Text] [Related]
7. 18F-Fluciclovine-Avid Pulmonary Hamartoma.
Baldeosingh SC; Rowe SP; Greco SC; Paller CJ; Goel R
Clin Nucl Med; 2021 Nov; 46(11):919-921. PubMed ID: 34582137
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. Incidental 18F-Fluciclovine Uptake in a Desmoid Tumor Detected in a Patient Undergoing PET/CT Imaging for Prostate Cancer.
Baiomy A; Jensen CT; Ward JF; Chasen BA; Ravizzini GC
Clin Nucl Med; 2021 Apr; 46(4):355-357. PubMed ID: 33323736
[TBL] [Abstract][Full Text] [Related]
10. Is There Any Role for 18F-Fluciclovine PET/CT in the Presence of Undetectable PSA in Prostate Cancer Patients After Definitive Treatment?
Teyateeti A; Teyateeti A; Macapinlac HA; Lu Y
Clin Nucl Med; 2020 Sep; 45(9):672-678. PubMed ID: 32604105
[TBL] [Abstract][Full Text] [Related]
11. Incidental Detection of Urothelial Carcinoma on 18F-Fluciclovine PET/CT.
Surasi DSS; Lu Y; Corn P; Pettaway C; Bathala T
Clin Nucl Med; 2021 Feb; 46(2):e114-e115. PubMed ID: 33156041
[TBL] [Abstract][Full Text] [Related]
12. 18F-Fluciclovine PET/CT: A Potential Imaging Biomarker for the Evaluation of Multiple Myeloma.
Marcus C; Schuster DM; Tajmir SH
Clin Nucl Med; 2022 Sep; 47(9):e613-e615. PubMed ID: 35930716
[TBL] [Abstract][Full Text] [Related]
13. Small Lymph Node Metastasis Detected by 68Ga-Prostate-Specific Membrane Antigen But Not 18F-Fluciclovine PET/CT in Low-Prostate-Specific Antigen Biochemical Recurrence of Prostate Cancer.
Chaussé G; Abikhzer G; Probst S
Clin Nucl Med; 2018 Apr; 43(4):250-251. PubMed ID: 29465489
[TBL] [Abstract][Full Text] [Related]
14. Initial Institutional Experience with 18F-Fluciclovine PET-CT in Biochemical Recurrence of Prostate Cancer.
Farkas AB; Green ED; Thaggard AL; Vijayakumar V; Henegan JC; Lirette ST; Nittala MR; Vijayakumar S
South Med J; 2021 Nov; 114(11):703-707. PubMed ID: 34729614
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for
Kim EH; Siegel BA; Teoh EJ; Andriole GL;
Urol Oncol; 2021 Jun; 39(6):365.e9-365.e16. PubMed ID: 33160848
[TBL] [Abstract][Full Text] [Related]
16. Rate of incidental central nervous system meningioma detected in patients undergoing 18F-fluciclovine PET/CT imaging for evaluation of prostate cancer.
Baiomy A; Schellingerhout D; Chapin BF; Weinberg JS; Raza SM; Macapinlac H; Ravizzini G
Nucl Med Commun; 2021 Jul; 42(7):755-762. PubMed ID: 33741867
[TBL] [Abstract][Full Text] [Related]
17. 18F-Fluciclovine-Avid Mediastinal Lymph Node Metastasis of Cutaneous Malignant Melanoma.
Shariftabrizi A; Pillenahalli Maheshwarappa R; Kahn D; Pollard J
Clin Nucl Med; 2021 Feb; 46(2):e97-e99. PubMed ID: 33031240
[TBL] [Abstract][Full Text] [Related]
18. Incidental Uptake of 18F-Fluciclovine by Type AB Thymoma.
Somnay V; Dalal I
Clin Nucl Med; 2022 Feb; 47(2):e116-e117. PubMed ID: 35006112
[TBL] [Abstract][Full Text] [Related]
19. Incidental Detection of Lung Adenocarcinoma Presenting as an Anterior Mediastinal Mass on 18F-Fluciclovine PET/CT in a Patient With Primary Prostate Cancer.
Abiodun-Ojo OA; Akintayo AA; Sica GL; Alemozaffar M; Schuster DM
Clin Nucl Med; 2020 Dec; 45(12):e525-e527. PubMed ID: 32701811
[TBL] [Abstract][Full Text] [Related]
20. 18F-Fluciclovine PET/CT Detection of Recurrent Prostate Carcinoma in Patients With Serum PSA ≤ 1 ng/mL After Definitive Primary Treatment.
England JR; Paluch J; Ballas LK; Jadvar H
Clin Nucl Med; 2019 Mar; 44(3):e128-e132. PubMed ID: 30589673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
